Cas no 717881-06-6 (6-Methyl-7-nitro-1H-indazole)

6-Methyl-7-nitro-1H-indazole is a heterocyclic organic compound featuring an indazole core substituted with a methyl group at the 6-position and a nitro group at the 7-position. This structure imparts unique reactivity, making it a valuable intermediate in pharmaceutical and agrochemical synthesis. Its nitro group enhances electrophilic properties, facilitating further functionalization, while the methyl group can influence steric and electronic effects. The compound is particularly useful in the development of biologically active molecules, including kinase inhibitors and other therapeutic agents. High purity grades are available to ensure consistency in research and industrial applications. Proper handling is advised due to potential sensitivity to light and heat.
6-Methyl-7-nitro-1H-indazole structure
6-Methyl-7-nitro-1H-indazole structure
Product Name:6-Methyl-7-nitro-1H-indazole
CAS No:717881-06-6
MF:C8H7N3O2
MW:177.160081148148
MDL:MFCD01851383
CID:558293
PubChem ID:1480032
Update Time:2025-06-09

6-Methyl-7-nitro-1H-indazole Chemical and Physical Properties

Names and Identifiers

    • 6-Methyl-7-nitro-1H-indazole
    • 1H-Indazole,6-methyl-7-nitro-
    • 6-METHYL-7-NITRO (1H)INDAZOLE
    • AC1LRZNI
    • AG-G-81785
    • CTK5D5045
    • HMS2604D22
    • MolPort-001-684-156
    • AMY9940
    • FT-0734282
    • BCP21278
    • 10P-900
    • AKOS006278767
    • MFCD01851383
    • SMR000337090
    • CS-0102835
    • J-518905
    • DTXSID10363178
    • CHEMBL1459798
    • SY019895
    • A866367
    • 717881-06-6
    • MLS000721464
    • 6-methyl-7-nitro-2H-indazole
    • DB-074473
    • MDL: MFCD01851383
    • Inchi: 1S/C8H7N3O2/c1-5-2-3-6-4-9-10-7(6)8(5)11(12)13/h2-4H,1H3,(H,9,10)
    • InChI Key: MFJNZLMQVJRCIW-UHFFFAOYSA-N
    • SMILES: [O-][N+](C1=C(C)C=CC2C=NNC=21)=O

Computed Properties

  • Exact Mass: 177.05391
  • Monoisotopic Mass: 177.054
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 1
  • Hydrogen Bond Acceptor Count: 2
  • Heavy Atom Count: 13
  • Rotatable Bond Count: 1
  • Complexity: 216
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • Surface Charge: 0
  • Tautomer Count: 2
  • XLogP3: 1.7
  • Topological Polar Surface Area: 74.5A^2

Experimental Properties

  • Density: 1.437
  • PSA: 71.82

6-Methyl-7-nitro-1H-indazole Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Alichem
A269001099-250mg
6-Methyl-7-nitro-1H-indazole
717881-06-6 95%
250mg
$155.00 2023-09-01
Alichem
A269001099-1g
6-Methyl-7-nitro-1H-indazole
717881-06-6 95%
1g
$380.24 2023-09-01
Alichem
A269001099-5g
6-Methyl-7-nitro-1H-indazole
717881-06-6 95%
5g
$1174.63 2023-09-01
TRC
B498503-1mg
6-methyl-7-nitro-1H-indazole
717881-06-6
1mg
$ 50.00 2022-06-07
TRC
B498503-2mg
6-methyl-7-nitro-1H-indazole
717881-06-6
2mg
$ 65.00 2022-06-07
TRC
B498503-10mg
6-methyl-7-nitro-1H-indazole
717881-06-6
10mg
$ 115.00 2022-06-07
Chemenu
CM128829-1g
6-methyl-7-nitro-1H-indazole
717881-06-6 95%
1g
$209 2021-08-05
SHANG HAI XIAN DING Biotechnology Co., Ltd.
B-ZU639-200mg
6-Methyl-7-nitro-1H-indazole
717881-06-6 95+%
200mg
932.0CNY 2021-07-14
SHANG HAI XIAN DING Biotechnology Co., Ltd.
B-ZU639-50mg
6-Methyl-7-nitro-1H-indazole
717881-06-6 95+%
50mg
372.0CNY 2021-07-14
Chemenu
CM128829-250mg
6-methyl-7-nitro-1H-indazole
717881-06-6 95%+
250mg
$112 2024-07-24

Additional information on 6-Methyl-7-nitro-1H-indazole

6-Methyl-7-nitro-1H-indazole (CAS No. 717881-06-6): An Overview of Its Synthesis, Properties, and Applications

6-Methyl-7-nitro-1H-indazole (CAS No. 717881-06-6) is a unique and versatile compound that has garnered significant attention in the fields of organic chemistry, medicinal chemistry, and pharmaceutical research. This compound, characterized by its distinctive molecular structure, exhibits a range of properties that make it a valuable candidate for various applications, including drug discovery and materials science.

The synthesis of 6-methyl-7-nitro-1H-indazole involves a series of well-defined chemical reactions. One common approach is the reaction of 7-amino-1-methylindazole with nitric acid, followed by methylation to introduce the methyl group at the 6-position. This method has been optimized to achieve high yields and purity, making it suitable for large-scale production. Recent advancements in synthetic methodologies have also explored the use of green chemistry principles to minimize environmental impact and improve sustainability.

In terms of physical properties, 6-methyl-7-nitro-1H-indazole is a solid compound with a molecular weight of 189.15 g/mol. It is sparingly soluble in water but exhibits good solubility in organic solvents such as dimethyl sulfoxide (DMSO) and dimethylformamide (DMF). The compound's stability under various conditions has been extensively studied, and it has been found to be stable at room temperature and under normal atmospheric conditions. However, it is sensitive to strong acids and bases, which can lead to degradation or decomposition.

The spectroscopic properties of 6-methyl-7-nitro-1H-indazole have been thoroughly characterized using techniques such as nuclear magnetic resonance (NMR), infrared (IR), and mass spectrometry (MS). These analyses have provided valuable insights into the compound's molecular structure and functional groups. For instance, the presence of the nitro group at the 7-position results in characteristic absorption bands in the IR spectrum, while the methyl group at the 6-position contributes to specific peaks in the NMR spectrum.

One of the most significant areas of research involving 6-methyl-7-nitro-1H-indazole is its potential as a pharmaceutical agent. Studies have shown that this compound exhibits potent biological activities, including anti-inflammatory, antimicrobial, and anticancer properties. For example, recent research has demonstrated that 6-methyl-7-nitro-1H-indazole can inhibit the proliferation of various cancer cell lines by inducing apoptosis and disrupting cell cycle progression. These findings have sparked interest in its development as a novel therapeutic agent for cancer treatment.

In addition to its pharmaceutical applications, 6-methyl-7-nitro-1H-indazole has also been explored for its use in materials science. Its unique electronic properties make it a promising candidate for the development of organic semiconductors and photovoltaic materials. Research in this area has focused on optimizing the compound's electronic structure to enhance its performance in these applications. For instance, studies have shown that modifying the substituents on the indazole ring can significantly affect its electronic properties and improve its efficiency as a semiconductor material.

The toxicological profile of 6-methyl-7-nitro-1H-indazole has been evaluated to ensure its safety for both human use and environmental impact. Preclinical studies have indicated that the compound has low toxicity when administered at therapeutic doses. However, it is important to note that further research is needed to fully understand its long-term effects and potential side effects. Regulatory agencies such as the FDA and EMA are closely monitoring ongoing studies to ensure that any new products containing this compound meet stringent safety standards.

Recent advancements in computational chemistry have also contributed to our understanding of 6-methyl-7-nitro-1H-indazole. Molecular modeling studies have provided insights into its binding interactions with various biological targets, helping researchers design more effective derivatives with enhanced potency and selectivity. These computational tools have also been used to predict the pharmacokinetic properties of the compound, which is crucial for optimizing its therapeutic potential.

In conclusion, 6-methyl-7-nitro-1H-indazole (CAS No. 717881-06-6) is a multifaceted compound with a wide range of applications in both pharmaceutical and materials science research. Its unique chemical structure and biological activities make it an attractive candidate for further development as a therapeutic agent and advanced material. Ongoing research continues to uncover new possibilities for this intriguing compound, highlighting its potential to contribute significantly to various scientific fields.

Recommended suppliers
Jiangxi Boyang Pharmaceutical Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jiangxi Boyang Pharmaceutical Chemical Co., Ltd
Shaanxi pure crystal photoelectric technology co. LTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Shaanxi pure crystal photoelectric technology co. LTD
Hubei Cuiyuan Biotechnology Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hubei Cuiyuan Biotechnology Co.,Ltd
Nanjing Jubai Biopharm
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Nanjing Jubai Biopharm
Xiamen PinR Bio-tech Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Xiamen PinR Bio-tech Co., Ltd.